Programmed cell death and the proteasome

Apoptosis

Volumn 3, Issue 1, 1998, Pages 1-7

  Drexler, H C A ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Apoptosis; Cell cycle; Differentiation; p27Kip1; Proteasome

Indexed keywords

EID: 0001842889     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009604900979     Document Type: Article

References (41)

1. Lam YA, Xu W, Demartino GN, Cohen RE. Editing of ubiquitin conjugates by an isopeptidase in the 26s proteasome. Nature 1997; 385: 737-740.
2. Phillips ME, Platt JE. The use of ubiquitin as a marker of thyroxine-induced apoptosis in cultured Rana catesbeiana tail tips. Gen Comp Endocrinol 1994; 95: 409-415.
3. Schwartz LM, Myer A, Kosz L, Engelstein M, Maier C. Activation of polyubiquitin gene expression during developmentally programmed cell death. Neuron 1990; 5: 411-419.
4. Dawson SP, Arnold JE, Mayer NJ, et al. Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J Biol Chem 1995; 270: 1850-1858.
5. Loew P, Bussell K, Dawson SP, et al. Expression of a 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca Sexta. FEBS Lett 1997; 400: 345-349.
6. Dawson S, Hastings R, Takayanagi K, et al. The 26S-proteasome - regulation and substrate recognition. Mol Biol Reports 1997; 24(1-2): 39-44.
7. Hashimoto MK, Mykles DL, Schwartz LM, Fahrbach SE. Imaginal cell-specific accumulation of the multicatalytic proteinase complex (proteasome) during post-embryonic development in the tobacco hornworm, Manduca sexta. J Comp Neurol 1996; 365: 329-341.
8. Fahrbach SE, Schwartz LM. Localization of immunoreactive ubiquitin in the nervous system of the Manduca sexta moth. J Comp Neurol 1994; 343: 464-482.
9. Gai WP, Blessing WW, Blumbergs PC. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 1995; 118: 1447-1459.
10. Wightman G, Anderson VER, Martin J, et al. Hippocampal and neocortical ubiquitin immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 1992; 139: 269-274.
11. Swaab DF, Grundke-Iqbal I, Iqbal K, et al. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res 1992; 590: 239-249.
12. Wang GP, Khatoon S, Iqbal K, Grundke II. Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res 1991; 566: 146-151.
13. Mundy DI. Identification of the multicatalytic enzyme as a possible gamma-secretase for the amyloid precursor protein. Biochem Biophys Res Comm 1994; 204: 333-341.
14. Gregori L, Fuchs C, Figueiredo-Pereira ME, Van NWE, Goldgaber D. Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem 1995; 270: 19702-19708.
15. Hughes SR, Riedel NG, Sahasrabudhe SR. Beta-amyloid peptide interacts with zeta and S4 subunits of the proteasome complex. 25th Ann Meet Soc Neurosci, San Diego, California, USA, 1995; 21: 208.
16. Gregori L, Hainfeld JF, Simon MN, Goldgaber D. Binding of amyloid beta protein to the 20 S proteasome. J Biol Chem 1997; 272: 58-62.
17. Hoffman EK, Wilcox HM, Scott RW, Siman R. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. J Neurol Sci 1996; 139: 15-20.
18. Omura S, Fujimoto T, Otoguro K, et al. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells [letter]. J Antibiot (Tokyo) 1991; 44: 113-116.
19. Fenteany G, Standaert RF, Reichard GA, Corey EJ, Schreiber SL. A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc Natl Acad Sci USA 1994; 91: 3358-3362.
20. Imajoh Ohmi S, Kawaguchi T, Sugiyama S, et al. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem Biophys Res Comm 1995; 217: 1070-1077.
21. Fujita E, Mukasa T, Tsukahara T, et al. Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem Biophys Res Comm 1996; 224: 74-79.
22. Drexler HCA. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 1997; 94: 855-860.
23. Shinohara K, Tomioka M, Nakano H, et al. Apoptosis induction resulting from proteasome inhibition. Biochem J 1996; 317: 385-388.
24. Tanimoto Y, Onishi Y, Hashimoto S, Kizaki H. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J Biochem 1997; 121: 542-549.
25. Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269: 682-685.
26. Catzavelos C, Bhatacharya N, Ung YC, et al. Decreased levels of the cell-cycle inhibitor p27(Kip1) protein - prognostic implications in primary breast cancer. Nature Med 1997; 3: 227-230.
27. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997; 3: 231-234.
28. Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27(Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 1997; 3: 222-225.
29. Rolfe M, Chiu MI, Pagano M. The ubiquitin-mediated proteolytic pathway as a therapeutic area. J Mol Med 1997; 75: 5-17.
30. Wang CY, Mayo MW, Baldwin AS. TNF- and cancer therapy-induced apoptosis - potentiation by inhibition of NF-kappa-B. Science 1996; 274: 784-787.
31. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappa-B. Science 1996; 274: 787-789.
32. Beg AA, Baltimore D. An essential role for NF-kappa-B in preventing TNF-alpha-induced cell death. Science 1996; 274: 782-784.
33. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM, Osborne BA. Proteasomes play an essential role in thymocyte apoptosis. EMBO J 1996; 15: 3835-3844.
34. Sadoul R, Fernandez P-A, Quiquerez A-L, et al. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J 1996; 15: 3845-3852.
35. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78: 761-771.
36. Akiyama KY, Yokota KY, Kagawa S, et al. CDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y. Science 1994; 265: 1231-1234.
37. Boes B, Hengel H, Ruppert T, et al. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 1994; 179: 901-909.
38. Delic J, Morange M, Magdelenat H. Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis. Mol Cell Biol 1993; 13: 4875-4883.
39. Kobayashi T, Shinozaki A, Momoi T, Arahata K, Tsukahara T. Identification of an interleukin-1-beta converting enzyme-like activity that increases upon treatment of P19 cells with retinoic acid as the proteasome. J Biochem 1996; 120: 699-704.
40. Boldin MP, Mett IL, Wallach D. A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett 1995; 367: 39-44.
41. Wright DA, Futcher B, Ghosh P, Geha RS. Association of human Fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP). J Biol Chem 1996; 271: 31037-31043.